If you are a man in Malaysia and you have never been offered the HPV vaccine, you are not alone. For years, public health campaigns have positioned HPV Vaccine almost exclusively as a vaccine for girls and women. School immunisation programmes provide it to schoolgirls. The messaging focuses on cervical cancer. Men rarely hear their name mentioned.
This has created a significant blind spot. HPV does not check gender. The same strains that cause cervical cancer in women cause genital warts, anal cancer, penile cancer, and throat cancer in men. And the same vaccine that protects women protects men equally well.
This article is for Malaysian men who want to understand what HPV actually does to the male body, who should get vaccinated, and why waiting is not a neutral decision.
HPV 9-valent Vaccine is approved for males aged 9 to 45 in Malaysia. It protects against 9 HPV strains responsible for genital warts, anal cancer, penile cancer, and oropharyngeal (throat) cancer. It is available at private clinics including Vivardi Clinics in Rawang. It is not part of Malaysia’s national immunisation programme for males, so you need to seek it out yourself.
What Is HPV and Why Should Men Care?
Human papillomavirus (HPV) is the most common sexually transmitted infection in the world. Most adults who are sexually active will be infected with at least one strain of HPV at some point in their lives. The majority of infections clear on their own without causing symptoms or lasting damage. The problem is that some strains do not clear. They persist, and over months or years, they can cause serious disease.
There are over 200 known strains of HPV. They are divided broadly into low-risk and high-risk categories. Low-risk strains, particularly HPV 6 and 11, cause genital warts. High-risk strains, particularly HPV 16 and 18, are the primary drivers of cancer.
According to the World Health Organization’s HPV fact sheet, HPV causes virtually all cervical cancers, but it is also responsible for a significant proportion of anal cancers, oropharyngeal cancers, penile cancers, vulvar cancers, and vaginal cancers across both sexes.
In men specifically, the HPV-related disease burden includes:
- Genital warts — caused by HPV 6 and 11, highly contagious, recurrent, and distressing even when not medically dangerous
- Anal cancer — HPV 16 and 18 account for approximately 90% of anal cancers
- Penile cancer — HPV is responsible for around 50% of penile cancer cases globally
- Oropharyngeal cancer — cancer of the back of the throat, base of tongue, and tonsils. HPV-positive oropharyngeal cancer rates have been rising sharply in many countries, particularly among men
- Transmission to partners — an unvaccinated man with HPV can transmit the virus to female or male partners, contributing to cervical cancer, anal cancer, and other HPV-related conditions in those partners
What Does HPV 9-valent Vaccine Cover?
HPV 9-valent Vaccine is the current generation of the HPV vaccine. The “9” refers to the nine HPV strains it targets. Understanding what these strains cause helps explain why the vaccine matters for men.
| HPV Strain | Classification | What It Causes |
|---|---|---|
| HPV 6 | Low-risk | Genital warts (90% of cases), laryngeal papillomas |
| HPV 11 | Low-risk | Genital warts (90% of cases), laryngeal papillomas |
| HPV 16 | High-risk | Cervical, anal, penile, oropharyngeal, vulvar, vaginal cancers |
| HPV 18 | High-risk | Cervical, anal, and other anogenital cancers |
| HPV 31, 33, 45, 52, 58 | High-risk | Additional cervical and anogenital cancers |
Together, these 9 strains are responsible for approximately 90% of genital warts and around 80 to 90% of HPV-related cancers. For men, protection against HPV 6, 11, 16, and 18 alone is already highly significant.
The Evidence: What Clinical Trials Show for Men
HPV 9-valent Vaccine did not receive approval for males based on assumption. The approval was based on clinical trial data specifically involving male participants.
The pivotal study for HPV vaccination in males, published in The New England Journal of Medicine, enrolled over 4,000 male participants aged 16 to 26. The trial demonstrated that the HPV vaccine reduced the incidence of genital warts caused by HPV 6 and 11 by approximately 90% in vaccinated males. The study also showed significant protection against anal intraepithelial neoplasia (a precancerous condition) caused by high-risk HPV strains.
Subsequent immunogenicity and efficacy data have consistently shown that the vaccine produces strong antibody responses in men across all age groups studied, with no meaningful difference in protective efficacy between males and females.
Who Should Get HPV 9-valent Vaccine in Malaysia?
HPV 9-valent Vaccine is approved for males aged 9 to 45 years in Malaysia. The practical question is who benefits most and at what stage of life vaccination is most valuable.
Ideal Age: Before Sexual Debut
The vaccine is most effective when administered before any HPV exposure. For this reason, adolescent boys aged 11 to 14 represent the highest benefit group. At this age, a 2-dose schedule separated by 6 months may be sufficient, as the immune response is particularly robust in younger individuals.
Young Adult Men (15 to 26)
Even for men who are already sexually active, vaccination at this age provides significant benefit. HPV has multiple strains, and exposure to one strain does not confer immunity to others. Most sexually active individuals have not been exposed to all 9 strains covered by HPV 9-valent Vaccine. Three doses are required for this age group.
Men Aged 27 to 45
For men in this age range, the benefit is more individualised. Men who are in new relationships, who have multiple sexual partners, or who have not previously been vaccinated should discuss their specific risk profile with a doctor. The vaccine still provides protection against strains not yet encountered, even at older ages.
Men Who Have Sex With Men (MSM)
MSM have a significantly higher risk of HPV-related anal cancer compared to the general population. Vaccination is particularly recommended for this group, regardless of age, as anal cancer risk from HPV is substantially higher than in the general male population.
As of 2026, Malaysia’s national immunisation programme provides HPV vaccination to schoolgirls in Year 1 and Form 1. There is no equivalent programme for boys or adult males. Men who want HPV protection must seek it out at private clinics and pay out of pocket. This is a significant public health gap.
Myths About HPV Vaccination for Men
The HPV 9-valent Vaccine Schedule for Men
First Dose (Day 0)
Administered as an intramuscular injection, typically into the upper arm. The injection takes less than a minute. You will be observed for 15 minutes post-injection as a precaution against rare fainting episodes.
Second Dose (Month 2)
Given approximately 2 months after the first dose. It is important to maintain the recommended interval for full immune response development.
Third Dose (Month 6)
Given 6 months after the first dose. After this final dose, the primary vaccination series is complete and provides long-lasting protection. Booster doses have not been required based on current evidence.
For males aged 9 to 14 who have not yet been sexually active, some guidelines allow for a 2-dose schedule: first dose on day 0, second dose 6 to 12 months later. This is because the immune response in younger adolescents is sufficiently strong with just 2 doses. Discuss with your doctor whether this applies to your child.
Side Effects: What to Expect
HPV 9-valent Vaccine has an extensive safety record across hundreds of millions of doses administered worldwide. The side effects are generally mild and temporary.
| Side Effect | Frequency | Duration |
|---|---|---|
| Injection site pain | Very common (1 in 3 people) | 1 to 3 days |
| Injection site redness or swelling | Common | 1 to 3 days |
| Headache | Common | 1 to 2 days |
| Mild fever | Less common | 1 to 2 days |
| Fatigue | Less common | 1 to 2 days |
| Fainting (vasovagal) | Rare | Immediately post-injection — resolved with observation |
| Serious allergic reaction | Very rare | Managed at clinic if it occurs |
Do not receive HPV 9-valent Vaccine if you have had a severe allergic reaction to a previous dose of any HPV vaccine, or if you are allergic to any ingredient in the vaccine including yeast. Inform your doctor of all current medications and any known allergies before vaccination.
HPV 9-valent Vaccine, HPV Warts, and the Connection to Male Sexual Health
For men attending Vivardi Clinics for men’s sexual health concerns, it is worth understanding how HPV vaccination fits into the broader picture of sexual health protection.
Men who have genital warts caused by HPV 6 or 11 should be aware that HPV 9-valent Vaccine does not treat existing warts. Existing warts need to be removed through HPV warts removal treatment at a clinic. Vaccination after wart removal helps prevent future recurrence from other strains and reduces the risk of transmitting HPV to partners.
Similarly, men who have received adult circumcision should note that circumcision reduces but does not eliminate HPV transmission risk. Circumcision and HPV vaccination together provide complementary layers of protection.
If you are concerned about possible HPV exposure or current STD status, comprehensive STD screening is available at Vivardi Clinics and can be done alongside vaccination consultation.
Cost of HPV 9-valent Vaccine in Malaysia for Men
HPV 9-valent Vaccine is not subsidised for males under Malaysia’s national immunisation programme. It is available at private clinics on a self-funded basis.
| Item | Estimated Cost (RM) | Notes |
|---|---|---|
| Per dose (private clinic) | RM 300 to RM 500 | Price varies by clinic and location |
| Full 3-dose course | RM 900 to RM 1,500 | Spread over 6 months |
| Consultation fee | May apply separately | Discuss with clinic at time of booking |
While the cost is significant, it is worth considering against the lifetime cost of treating HPV-related conditions. Genital wart treatment alone typically requires multiple sessions. Cancer treatment costs are substantially higher. Prevention is almost always the more economical option over a lifetime.
Frequently Asked Questions
Yes. If your previous warts were caused by HPV 6 or 11, vaccination can protect you against the other 7 strains covered by HPV 9-valent Vaccine, including the high-risk cancer-causing strains. It cannot reverse past infections or remove current warts, but it provides forward-looking protection.
Yes, adolescent boys benefit significantly from vaccination. Ages 11 to 14 represent the ideal window. At these ages, a 2-dose schedule may suffice and the immune response is strongest. The vaccine is safe, well-studied, and the protection lasts well into adulthood.
No. The vaccine protects against 9 HPV strains but does not protect against other sexually transmitted infections including HIV, chlamydia, gonorrhoea, and herpes. Condoms remain important for broader STI protection, particularly with new or multiple partners.
Yes, HPV 9-valent Vaccine can generally be co-administered with other vaccines such as Hepatitis B or influenza vaccine. Your doctor will advise on the most practical approach based on your overall vaccination schedule.
Current evidence from long-term follow-up studies suggests that protection from HPV 9-valent Vaccine lasts at least 10 to 12 years with no significant waning of antibody levels. Based on existing data, booster doses are not currently recommended, though ongoing surveillance studies continue to monitor long-term immunity.
This depends on your individual risk profile and history. Men who have had multiple sexual partners, who are entering new relationships, or who have never been vaccinated may still derive meaningful benefit. Discuss with your doctor who can assess your specific situation rather than applying a blanket rule.
Why Vivardi Clinics for HPV 9-valent Vaccine
At Vivardi Clinics in Rawang, we administer HPV 9-valent Vaccine as part of a broader approach to men’s sexual and preventive health. We understand that many male patients feel uncertain about whether vaccination applies to them or whether they are too old to benefit. Our consultation process addresses these questions directly, without judgment or pressure.
We can administer the vaccine on the same visit as a sexual health consultation, STD screening, or anonymous HIV testing, making it convenient to address multiple preventive health priorities in a single appointment.
Book Your HPV 9-valent Vaccine Consultation
Available for men of all ages. Walk-ins welcome. Confidential consultation with no obligation.
📞 011-8888 6503
Pusat Komersial Anggun City, 63A-1, Jalan Anggun City 2, Rawang, Selangor
Final Thought
The HPV vaccine was never designed to be only for women. It was designed to protect against a virus that does not discriminate between sexes. The gender imbalance in HPV vaccination coverage reflects historical marketing decisions and programme priorities, not medical reality.
Men who get vaccinated protect themselves against genital warts and HPV-related cancers. They also protect their partners. In public health terms, widespread male vaccination creates herd immunity that benefits the broader community.
If you have been waiting for a reason to get this done, this article is that reason.
Related treatment: learn more about HPV vaccination at Vivardi Clinics.
Medical Director
MBBS (AIMST), LCP Certified Aesthetic Physician, Cert. Men’s Health
Medically reviewed by Dr. Dinesh Kumar, Medical Director, Vivardi Clinics. MBBS (AIMST), LCP-Certified Aesthetic Physician, Cert. Men’s Health. Last reviewed October 2026.
Care at Vivardi is provided by our team of qualified doctors. This page is for general education and does not replace a personal consultation.
